Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-25-000371·PLIANT THERAPEUTICS, INC.
Schedule 13G ownership disclosure
PLIANT THERAPEUTICS INC
COMMON STOCK · CUSIP: 729139105
Event date: 2025-03-31
- Filing-level shares
- 87,674
- Percent of class
- 0.1%
- T. Rowe Price Associates, Inc.
Shares: 87,674 · Class: 0.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000371
- Form type
- SCHEDULE 13G/A
- Filer
- PLIANT THERAPEUTICS, INC.
- CIK
- CIK 1746473
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership